Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: GI Dynamics, Inc.

Market Cap 440K 384K 356K 333K 624K 41.56M 628K 4.22M 1.64M 20.46M 1.65M 1.62M 71.03M P/E 2019
-1.12x
P/E 2020 -0.03x
Enterprise Value 3.28M 2.86M 2.65M 2.48M 4.65M 309M 4.68M 31.42M 12.18M 152M 12.31M 12.05M 529M EV / Sales 2019
-
EV / Sales 2020 -
Free-Float
-
Yield 2019 *
-
Yield 2020 -
Manager TitleAgeSince
Chief Executive Officer - 05/08/2025
Director of Finance/CFO 57 01/08/2025
Chief Tech/Sci/R&D Officer - 01/04/2023
Director TitleAgeSince
Chairman 67 21/10/2020
Director/Board Member - 20/10/2020
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
28/01/21Free

Chief Executive Officer

11,075,869 3.8998%
28/01/21Free

Chairman

1,384,483 0.4875%

Financials

2019 2020
Net sales - -
Net income -17.33M -15.11M -14M -13.1M -24.57M -1.64B -24.72M -166M -64.35M -805M -65.06M -63.67M -2.8B -11.14M -9.71M -8.99M -8.42M -15.79M -1.05B -15.88M -107M -41.34M -517M -41.8M -40.9M -1.8B
Net Debt 2.89M 2.52M 2.33M 2.18M 4.09M 272M 4.12M 27.66M 10.72M 134M 10.84M 10.6M 466M 2.84M 2.48M 2.29M 2.15M 4.02M 268M 4.05M 27.2M 10.54M 132M 10.66M 10.43M 458M
Logo GI Dynamics, Inc.
GI Dynamics, Inc. is a medical device company. The Company designs and applies device and disease management solutions for the treatment of metabolic disease. The Company designs, develops, manufactures and markets medical devices for non-surgical approaches to treat type II diabetes and obesity. The Company's product, EndoBarrier, is an endoscopically-delivered device therapy, which is approved for the treatment of obese type II diabetes with body mass index (BMI) greater than or equal to 30 kilogram/square meter (kg/m2), or obese patients with BMI greater than or equal to 30 kg/m2 with greater than or equal to one comorbidities, or obese patients with BMI over 35 kg/m2. EndoBarrier is an incision-free, non-anatomy altering solution designed to specifically mimic the duodenal-jejunal exclusion created by gastric bypass surgery.
Employees
-
Sector
-
  1. Stock Market
  2. Stocks
  3. GIDYL Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!